Tag: Medication history

In the 1970s, the landscape of over-the-counter cough medicines underwent a significant transformation, largely abandoning potentially addictive opioid compounds in favor of safer ingredients. Understanding **what was the cough medicine in the 1970s?** reveals a pivotal shift towards modern, regulated pharmaceuticals.

In the UK's National Health Service (NHS), a PPA ID refers to a unique prescribing code for medical professionals, a fact often overshadowed by the acronym's association with the controversial drug, phenylpropanolamine. Understanding the context is crucial, as the two terms have vastly different meanings and implications within the fields of pharmacology and healthcare administration.

According to the National Institutes of Health, pharmacies are required to maintain detailed records for controlled substances for at least two years. This regulatory mandate is part of a broader system that answers the question: **Does Walgreens keep a record of prescriptions?** The short answer is yes, and for a variety of critical reasons, ranging from ensuring patient safety to tracking medication distribution.

Originally formulated with a type of clay, Kaopectate underwent a significant reformulation in the mid-2000s in the U.S., which changed **what is the active ingredient in Kaopectate?** from adsorbent clays to bismuth subsalicylate. This shift in formulation altered how the medication works to provide relief for various gastrointestinal issues.

The brand name medication Quibron has been discontinued in the U.S., but historically, understanding what are the ingredients in Quibron reveals a combination of a bronchodilator and an expectorant used for conditions like asthma and COPD. Its formulations typically included the active ingredients theophylline and guaifenesin, addressing both airway constriction and mucus buildup.

The US Food and Drug Administration (FDA) issued a public health advisory in 2000, requesting manufacturers voluntarily discontinue marketing products containing Phenylpropanolamine (PPA), including PPA drops. Once a common ingredient for nasal congestion and appetite control, PPA's human use was phased out due to serious safety concerns, namely an increased risk of hemorrhagic stroke. However, the compound still has limited, specific uses in veterinary medicine.

Finasteride was originally approved by the FDA in 1992 for the treatment of benign prostatic hyperplasia (BPH) under the brand name Proscar, with its use for male pattern hair loss following five years later. The story of **when did people start using finasteride** is one of scientific discovery and a fortunate observation during clinical trials.

First approved in 1996 as a breakthrough in HIV treatment, Crixivan (indinavir) was a landmark medication; however, today, **is CRIXIVAN still used** in clinical practice? The answer is no, as it has been largely discontinued due to significant side effects, complex dosing requirements, and the advent of superior, more tolerable treatments.

Once a widely available patent medicine in the United States, paregoric was reclassified as a controlled substance in 1970. It is now a Schedule III narcotic and cannot be purchased over-the-counter. The brand name has been discontinued, and while generic versions may exist by prescription, the drug is seldom prescribed today due to abuse potential and the availability of safer, more effective alternatives.

Introduced in 1955, meprobamate became a popular anxiety treatment, but today its brand names are discontinued, raising the question: **is meprobamate still prescribed in the US?**. While generic versions are available, its clinical use is now exceedingly rare due to significant safety concerns and the availability of safer alternatives.